IMMUNOVANT INC (IMVT) Stock Cash Flow
USA - NASDAQ:IMVT - US45258J1025 - Common Stock
15.29 USD
-0.24 (-1.55%)
15.29 USD
0 (0%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -447.30M | -413.84M | -259.34M | -210.96M | -156.73M | |||
| Depreciation Amortization | 404.00K | 377.00K | 231.00K | 190.00K | 130.00K | |||
| Change In Working Capital | -24.82M | -12.03M | 2.63M | -10.85M | 15.14M | |||
| Taxes Paid | N/A | 1.20M | 509.00K | N/A | 0.00 | |||
| Other non cash items | 54.63M | 49.62M | 42.25M | 33.43M | 35.35M | |||
| OPERATING CASH FLOW | -417.09M | -375.87M | -214.23M | -188.19M | -106.11M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -577.00K | -759.00K | -360.00K | -200.00K | -250.00K | |||
| INVESTING CASH FLOW | -577.00K | -759.00K | -360.00K | -200.00K | -250.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 457.04M | 454.81M | 478.44M | 71.16M | 0.00 | |||
| Other Financing Activity | N/A | -319.00K | -6.01M | -270.00K | 200.13M | |||
| FINANCING CASH FLOW | 456.72M | 454.49M | 472.43M | 70.89M | 200.13M | |||
| Exchange Rate Effect | -154.00K | 747.00K | 993.00K | 220.00K | -90.00K | |||
| CHANGE IN CASH | 38.91M | 78.61M | 258.83M | -117.28M | 93.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -417.09M | -375.87M | -214.23M | -188.19M | -106.11M | |||
| Capital Expenditure | -577.00K | -759.00K | -360.00K | -200.00K | -250.00K | |||
| FREE CASH FLOW | -417.66M | -376.63M | -214.59M | -188.39M | -106.36M | |||
All data in USD